Orbimed Advisors - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$3,151,145
-1.5%
1,583,4900.0%0.06%
+1.7%
Q3 2022$3,199,0001,583,4900.06%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$103,087,0005.89%
Eversept Partners, LP 6,440,572$30,850,3401.97%
TPG GP A, LLC 16,213,367$77,662,0000.78%
Signature Wealth Management Partners, LLC 87,666$420,0000.36%
Hedges Asset Management LLC 75,000$359,0000.28%
Hillsdale Investment Management Inc. 869,916$4,167,0000.28%
Tranquilli Financial Advisor LLC 71,414$342,0000.24%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$862,0000.19%
GLOBEFLEX CAPITAL L P 297,414$1,424,0000.15%
XTX Topco Ltd 23,742$114,0000.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders